Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3AAW

Crystal structure of aspartate kinase from Corynebacterium glutamicum in complex with lysine and threonine

Summary for 3AAW
Entry DOI10.2210/pdb3aaw/pdb
Related2DTJ 3AB2 3AB4
DescriptorAspartokinase, Aspartokinase LysC beta subunit, THREONINE, ... (5 entities in total)
Functional Keywordsaspartate kinase, concerted inhibition, alternative initiation, amino-acid biosynthesis, atp-binding, diaminopimelate biosynthesis, kinase, lysine biosynthesis, nucleotide-binding, transferase
Biological sourceCorynebacterium glutamicum (Brevibacterium flavum)
More
Total number of polymer chains4
Total formula weight129284.62
Authors
Yoshida, A.,Tomita, T.,Kuzuyama, T.,Nishiyama, M. (deposition date: 2009-11-27, release date: 2010-06-23, Last modification date: 2023-11-01)
Primary citationYoshida, A.,Tomita, T.,Kuzuyama, T.,Nishiyama, M.
Mechanism of concerted inhibition of {alpha}2{beta}2-type heterooligomeric aspartate kinase from Corynebacterium glutamicum
J.Biol.Chem., 285:27477-27486, 2010
Cited by
PubMed Abstract: Aspartate kinase (AK) is the first and committed enzyme of the biosynthetic pathway producing aspartate family amino acids, lysine, threonine, and methionine. AK from Corynebacterium glutamicum (CgAK), a bacterium used for industrial fermentation of amino acids, including glutamate and lysine, is inhibited by lysine and threonine in a concerted manner. To elucidate the mechanism of this unique regulation in CgAK, we determined the crystal structures in several forms: an inhibitory form complexed with both lysine and threonine, an active form complexed with only threonine, and a feedback inhibition-resistant mutant (S301F) complexed with both lysine and threonine. CgAK has a characteristic alpha(2)beta(2)-type heterotetrameric structure made up of two alpha subunits and two beta subunits. Comparison of the crystal structures between inhibitory and active forms revealed that binding inhibitors causes a conformational change to a closed inhibitory form, and the interaction between the catalytic domain in the alpha subunit and beta subunit (regulatory subunit) is a key event for stabilizing the inhibitory form. This study shows not only the first crystal structures of alpha(2)beta(2)-type AK but also the mechanism of concerted inhibition in CgAK.
PubMed: 20573952
DOI: 10.1074/jbc.M110.111153
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.5 Å)
Structure validation

227111

PDB entries from 2024-11-06

PDB statisticsPDBj update infoContact PDBjnumon